THURSDAY, Feb. 8, 2018 (HealthDay News) — Two cancer drugs can stall the progression of a particularly hard-to-treat form of prostate cancer, a pair of new trials shows. Both a newly developed drug called apalutamide and an already approved drug called enzalutamide (Xtandi) kept prostate cancer from spreading for twoContinue Reading

THURSDAY, Feb. 8, 2018 (HealthDay News) — Most Americans are not on board with President Donald Trump’s recent decision to further protect health care workers who refuse to treat patients on religious or moral grounds, the latest HealthDay/Harris Poll shows. More than eight of 10 surveyed do not believe doctors,Continue Reading